Last reviewed · How we verify
NCT06818370
The Effect of Coconut Oil on Alopecia
NA trial testing Coconut Oil in Breast Cancer in 86 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 86 |
| Start date | 3 February 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Coconut Oil
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Who can join
Adults 18 to 65, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06818370
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coconut Oil
Trials testing the same drug.
- NCT06379516 — Process Validation in Dermatology: Assessing Wound Creation Methods and Treatment Efficacy · NA · completed
- NCT06049589 — Therapeutic Application of Coconut Oil in Oral Health · NA · completed
- NCT05653362 — Coconut Oil vs. Commercial Ultrasound Gel In Obstetric Ultrasounds · NA · completed
- NCT03176368 — Coconut Oil: Managing Radiation-Induced Xerostomia · NA · unknown
- NCT03202654 — Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation · NA · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials
Trials by the same sponsor.
- NCT07394816 — Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery? · not yet recruiting
- NCT07509697 — Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated Pneumonia · completed
- NCT07440095 — Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve · not yet recruiting
- NCT07392086 — Comparison of FCV and VCV in One-Lung Ventilation · recruiting
- NCT07325617 — Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06818370 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Last refreshed: 12 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06818370.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing